12/17
09:00 am
cvkd
Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026
Medium
Report
Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026
12/11
08:27 am
cvkd
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) [Yahoo! Finance]
Medium
Report
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) [Yahoo! Finance]
12/11
08:05 am
cvkd
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
Medium
Report
Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)
12/1
09:00 am
cvkd
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
Low
Report
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors
11/19
08:00 am
cvkd
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
Medium
Report
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
11/17
03:25 pm
cvkd
Why the underdog mindset could be your business superpower [Yahoo! Finance]
Low
Report
Why the underdog mindset could be your business superpower [Yahoo! Finance]
11/10
03:55 pm
cvkd
Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18 [Seeking Alpha]
Low
Report
Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18 [Seeking Alpha]
11/10
09:00 am
cvkd
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Low
Report
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/8
12:52 pm
cvkd
Cadrenal Therapeutics, Inc. [Yahoo! Finance]
Low
Report
Cadrenal Therapeutics, Inc. [Yahoo! Finance]
9/29
04:56 pm
cvkd
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 [Yahoo! Finance]
Medium
Report
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 [Yahoo! Finance]
9/29
04:30 pm
cvkd
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Low
Report
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025